Benefits of Epoetin Alfa in Anemic Breast Cancer Patients Receiving Chemotherapy

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Chemotherapy-Induced Anemia in Adults: Incidence and Treatment

1999 • 918 citations

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

1997 • 775 citations

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1998 • 769 citations

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

1997 • 715 citations

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

2001 • 606 citations

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1995 • 563 citations

Fatigue and the cancer experience: the state of the knowledge.

1994 • 527 citations

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

1998 • 516 citations

Untitled

1998 • 474 citations

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

1998 • 474 citations

Cancer Nursing: Principles and Practice

1998 • 472 citations

Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment.

1978 • 468 citations

Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

1990 • 459 citations

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.

1995 • 389 citations

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

1996 • 387 citations

Fatigue in cancer patients

1993 • 345 citations

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

1995 • 324 citations

Quality of Life in Cancer: Definition, Purpose, and Method of Measurement

1993 • 320 citations

Cancer Nursing: Principles and Practice

1987 • 272 citations

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

1995 • 220 citations

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

1995 • 208 citations

Assessment of the quality of life of patients with advanced cancer

1983 • 186 citations

Fatigue in cancer patients: a review of the literature

1995 • 178 citations

Quality of life during and after cancer treatment.

1988 • 178 citations

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin

1994 • 171 citations

Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancer

1997 • 118 citations

Quality of life and the patient with cancer. Individual and policy implications

1994 • 106 citations

Recombinant Human Erythropoietin in the Treatment of the Anaemia of Cancer

1992 • 99 citations

Correlates of fatigue in survivors of breast cancer

1998 • 91 citations

Fatigue in cancer and HIV/AIDS.

1998 • 81 citations

Quality of life and the patient with cancer. Individual and policy implications

1994 • 78 citations

Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.

1995 • 47 citations

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.

1995 • 36 citations

Quality of life as an outcome of cancer treatment

1993 • 6 citations

Cited By (0)

Loading...